Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Signet Ring Cell Carcinoma”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableLooking for participantsNCT07207278
What this trial is testing

Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma

Who this might be right for
Signet Ring Cell Carcinoma of the Lung
First People's Hospital of Hangzhou 39
Large-scale testing (Phase 3)UnknownNCT03355612
What this trial is testing

XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

Who this might be right for
Gastric Carcinoma
Tianjin Medical University Cancer Institute and Hospital 456
Not applicableStudy completedNCT04253106
What this trial is testing

Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer

Who this might be right for
Hereditary Diffuse Gastric Cancer
Assistance Publique - Hôpitaux de Paris 16
Not applicableStudy completedNCT00633607
What this trial is testing

Hereditary Colorectal and Associated Tumor Registry Study

Who this might be right for
Lynch SyndromeFAPHereditary Diffuse Gastric Cancer+2 more
University of Pittsburgh 114
Large-scale testing (Phase 3)Study completedNCT01226394
What this trial is testing

Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients

Who this might be right for
Colorectal Cancer With a Resected Minimal Synchronous PCOvarian MetastasesTumour Rupture in the Abdominal Cavity
Gustave Roussy, Cancer Campus, Grand Paris 150
Not applicableStudy completedNCT01249859
What this trial is testing

Prognosis of Signet Ring Cells in Upper Digestive Neoplasms

Who this might be right for
Signet Ring Cell CarcinomaStomach DiseaseOesophagus+2 more
University Hospital, Lille 2,500
Not applicableWithdrawnNCT02594943
What this trial is testing

Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer

Who this might be right for
Stomach Neoplasms
Region Skane
Not applicableStudy completedNCT01824966
What this trial is testing

Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma

Who this might be right for
AdenocarcinomaEsophageal Cancer
University Hospital, Gasthuisberg 82
Not applicableStudy completedNCT06978595
What this trial is testing

Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies

Who this might be right for
Colorectal CarcinomaCancerSignet Ring Adenocarcinoma of the Colon
asmaa salama ibrahim 8,171
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Not applicableStudy completedNCT03950908
What this trial is testing

Biopsy Technique for Endoscopic Surveillance of Hereditary Diffuse Gastric Cancer

Who this might be right for
Hereditary Diffuse Gastric Cancer
University of Cambridge 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05504252
What this trial is testing

METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin

Who this might be right for
Colorectal AdenocarcinomaMucinous AdenocarcinomaSignet Ring Cell Adenocarcinoma
University Hospital, Akershus 80
Testing effectiveness (Phase 2)Ended earlyNCT00745134
What this trial is testing

Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+6 more
M.D. Anderson Cancer Center 22
Large-scale testing (Phase 3)Active Not RecruitingNCT01882933
What this trial is testing

D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma

Who this might be right for
Gastric Adenocarcinoma
Hospices Civils de Lyon 367
Not applicableUnknownNCT06192030
What this trial is testing

Machine Learning Predicts Survival and Mutations in Ovarian Metastases of Colorectal Cancer

Who this might be right for
Ovarian Metastases of Colorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 200
Not applicableUnknownNCT05985577
What this trial is testing

Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics

Who this might be right for
Gastric CancerSignet Ring Cell Carcinoma
Zhejiang Cancer Hospital 300
Large-scale testing (Phase 3)Study completedNCT00068692
What this trial is testing

Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+8 more
National Cancer Institute (NCI) 225
Testing effectiveness (Phase 2)Study completedNCT03648879
What this trial is testing

Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer Syndrome

Who this might be right for
Gastric CancerGastric Neoplasms
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Ended earlyNCT05001282
What this trial is testing

Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Who this might be right for
Ovarian CancerOvarian NeoplasmsOvarian Carcinoma+22 more
Elucida Oncology 79
Testing effectiveness (Phase 2)Looking for participantsNCT06487221
What this trial is testing

Avutometinib and Defactinib in Diffuse Gastric Cancer

Who this might be right for
Gastric CancerStomach Cancer
Ryan H. Moy, MD, PhD 27
Load More Results